The GISCO study plans to determine whether 8-week therapy is just as effective as 26-week cortisone therapy for treating giant cell arteritis
* with tocilizumab, * while using less cortisone.
Patients diagnosed with giant cell arteritis
Start of tocilizumab treatment at baseline as part of routine clinical practice
Receive ≥ 20 mg/day prednisone (or equivalent) at baseline
Written informed consent
Treated with any investigational drug of chemical or biologic nature within a minimum of 30 days or 5 half-lives (whichever is longer) prior to the first dose of tocilizumab.